552 results
8-K
ABT
Abbott Laboratories
17 Apr 24
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
7:36am
, certain regulatory costs, tax benefits associated with specified items, net tax expense as a result of the resolution of various tax positions related … to prior years, and excess tax benefits associated with share-based compensation. These non-GAAP financial measures also exclude intangible amortization
8-K
EX-99.1
brbnu6uxwc6nu5
24 Jan 24
Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook
7:36am
8-K
ndz 02ezdj
24 Jan 24
Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook
7:36am
8-K
EX-99.1
g7rsh0 6cs8tc19ul
18 Oct 23
Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
7:37am
8-K
ss289vyu
18 Oct 23
Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
7:37am
8-K
EX-99.1
10hfddv9 re
20 Jul 23
Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business
8:29am
8-K
70pu3pdlvx1unoqj47b
20 Jul 23
Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business
8:29am
11-K
7uwnz st6dhtot
23 Jun 23
Annual report of employee stock purchases
4:07pm
8-K
43dlknmiu9
12 Jun 23
Departure of Directors or Certain Officers
10:32am